The FDA has issued an advisory warning to physicians and patients about potential health risks from topical anesthetic lidocaine used to reduce the discomfort of breast compression during mammography.
The FDA has issued an advisory warning to physicians and patients about potential health risks from topical anesthetic lidocaine used to reduce the discomfort of breast compression during mammography.
Dr. Colleen K. Lambertz and colleagues at St. Luke's Mountain States Tumor Institute in Boise, ID, discussed the potential value of nonprescription lidocaine gel spread before mammography in the September 2008 issue of Radiology (248[3]:765-771). Lambertz reported that lidocaine produced a few minor side effects, but the FDA noted in January that the study was not large enough to evaluate the potential for serious reactions. The deaths of two women who used topical anesthetics prior to laser hair removal led the FDA to issue in early 2007 an advisory on potentially lifethreatening side effects of skin products containing numbing ingredients and guidelines for safer use.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.